Technology is becoming more prevalent in practice, so it's crucial that practices choose the right technology to deliver care, said Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health.
Technology is becoming more prevalent in practice, so it's crucial that practices choose the right technology to deliver care, said Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health.
Transcript
How much do community oncologists rely on new technology not only to deliver better care to patients, but also to keep their business competitive?
It’s becoming more and more prevalent in practice today. So, I would say 5 years ago, technology was an afterthought. It was something that people did during the launch of the Affordable Care Act when meaningful use came out saying that you must have an EHR [electronic health record]. And people sort of did that as a check the box: I am going to implement this because the government says I have to by 2009, I believe, or 2010. So people used it but they didn’t actually use the technology. They actually just used it as a storage system.
I think in the last 18 months, practices have realized that technology is going to be be crucial for their success. Now, and in the future. It is probably one of the fastest-growing investments that community oncology practices are making in their businesses today. But I think the problem is they’re not sure of which investments to make. Because the cost is high for new systems, new technology, and right now you’re not getting paid for implementing these things. When you make a large investment, typically in a business, you hope that that investment will pay a return investment.
Right now, because the payment models aren’t changing fast enough, but you’re expected to be there at some point without the infrastructure to build towards it, practices are making investments hoping that it’ll get paid for in the future. And making the right investment is the important thing. So you make the wrong one, you’ll have this massive investment in the wrong technology that then won’t allow you to be successful in the future.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More